Advances in the treatment of Alzheimer's disease.
Schneider
L S
LS
Chair of Psychiatry, Neurology and Gerontology, University of Southern California, Los Angeles, USA.
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D018697:Nootropic Agents / Q000627:therapeutic use; D012642:Selegiline / Q000627:therapeutic use; D013619:Tacrine / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D018696:Neuroprotective Agents; D018697:Nootropic Agents; D014810:Vitamin E; D012642:Selegiline; D013619:Tacrine